Influence of platelet reactivity on outcome of patients with acute myocardial infarction undergoing primary angioplasty

Circulation Journal

Volumn 75, Issue 9, 2011, Pages 2050-2051

  Patti, Giuseppe ^a   Nusca, Annunziata ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ACUTE HEART INFARCTION; BLEEDING; CARDIOVASCULAR PARAMETERS; DRUG DOSE COMPARISON; DRUG MEGADOSE; EDITORIAL; HIGH RESIDUAL PLATELET REACTIVITY; HUMAN; LOADING DRUG DOSE; PATHOGENESIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE ACTIVATION; TREATMENT RESPONSE;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 80052162294     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0806     Document Type: Editorial

References (16)

1. Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, et al. Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis. Am Heart J 2010; 160: 543-551.
2. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO study. J Am Coll Cardiol 2008; 52: 1128-1133.
3. Michelson AD. Methods for the measurement of platelet function. Am J Cardiol 2009; 103: 20A-26A.
4. Vavuranakis M, Vrachatis DA, Papaioannou TG, Archontakis S, Kalogeras KI, Kariori MG, et al. Residual platelet reactivity after clopidogrel loading in patients with ST-elevation myocardial infarction undergoing an unexpectedly delayed primary percutaneous coronary intervention: Impact on intracoronary thrombus burden and myocardial perfusion. Circ J 2011; 75: 2105-2112.
5. Campo G, Valgimigli M, Gemmati D, Percoco G, Catozzi L, Frangione A, et al. Poor responsiveness to clopidogrel: Drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. J Am Coll Cardiol 2007; 50: 1132-1137.
6. Frossard M, Fuchs I, Leitner JM, Hsieh K, Vlcek M, Losert H, et al. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 2004; 110: 1392-1397.
7. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al; TRITON-TIMI 38 investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): Double-blind, randomised controlled trial. Lancet 2009; 373: 723-731.
8. Brar SS, ten Berg J, Marcucci R, Price NJ, Valgimigli M, Kim HS, et al. Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: Collaborative meta-analysis of individual participant data. J Am Coll Cardiol 2011 (in press).
9. Price MJ, Berger PB, Teirstein PS, Tanguay JF, Angiolillo DJ, Spriggs D, et al; GRAVITAS Investigators. Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial. JAMA 2011; 305: 1097-1105.
10. Patti G, Pasceri V, Di Sciascio G. Standard-vs high-dose clopidogrel after percutaneous coronary intervention. JAMA 2011; 305: 2520-2521.
11. Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol 2011; 107: 995-1000.
12. Mangiacapra F, Patti G, Peace A, Gatto L, Vizzi V, Ricottini E, et al. Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention. Am J Cardiol 2010; 106: 619-623.
13. Ernst NM, Suryapranata H, Miedema K, Slingerland RJ, Ottervanger JP, Hoorntje JC, et al. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44: 1187-1193.
14. Patti G, Colonna G, Pasceri V, Lassandro Pepe L, Montinaro A, Di Sciascio G. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 study. Circulation 2005; 111: 2099-2106.
15. Dangas G, Mehran R, Guagliumi G, Caixeta A, Witzenbichler B, Aoki J, et al; HORIZONS-AMI Trial Investigators. Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: Results from the HORIZONS-AMI trial. J Am Coll Cardiol 2009; 54: 1438-1446.
16. Patti G, Bárczi G, Orlic D, Mangiacapra F, Colonna G, Pasceri V, et al. Outcomes comparison of 600 mg vs 300 mg loading dose of clopidogrel in patients undergoing primary percutaneous coronary interventions for ST-segment elevation myocardial infarction: Results from the Armyda 6 MI. J Am Coll Cardiol 2011 (in press).